Hydrochloric Acid → 2-(1-(2-(dimethylamino)ethyl)-6-methyl-1H-indazol-3-yl)-N-(1-hydroxy-2-methylpropan-2-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide hydrochloride
Reaction equation
[Si]([O:8][CH2:9][C:10]([NH:13][C:14]([C:16]1[C:24]2[C:19](=[N:20][CH:21]=[C:22]([C:25]3[C:33]4[C:28](=[CH:29][C:30]([CH3:34])=[CH:31][CH:32]=4)[N:27]([CH2:35][CH2:36][N:37]([CH3:39])[CH3:38])[N:26]=3)[N:23]=2)[NH:18][CH:17]=1)=[O:15])([CH3:12])[CH3:11])(C(C)(C)C)(C)C.[ClH:40]>CO.C1COCC1>[ClH:40].[CH3:39][N:37]([CH3:38])[CH2:36][CH2:35][N:27]1[C:28]2[C:33](=[CH:32][CH:31]=[C:30]([CH3:34])[CH:29]=2)[C:25]([C:22]2[N:23]=[C:24]3[C:16]([C:14]([NH:13][C:10]([CH3:11])([CH3:12])[CH2:9][OH:8])=[O:15])=[CH:17][NH:18][C:19]3=[N:20][CH:21]=2)=[N:26]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of N-(1-(tert-butyldimethylsilyloxy)-2-methylpropan-2-yl)-2-(1-(2-(dimethylamino)ethyl)-6-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide (127 mg, 0.23 mmol) in 5 mL of methanol and 1 mL of THF was added 1 mL of concentrated HCl, then stirred for 3 hours. The precipitate was filtered and filter cake was washed with 2-methoxy-2-methylpropane (5 mL) to give 25 mg of 2-(1-(2-(dimethylamino)ethyl)-6-methyl-1H-indazol-3-yl)-N-(1-hydroxy-2-methylpropan-2-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide hydrochloride. LCMS: (M+H)+=436; 1H NMR (300 MHz, DMSO): δ 12.85 (s, 1H), 10.19 (s, 1H), 9.18 (s, 1H), 8.47 (d, 1H, J=8.1 Hz), 8.37 (s, 1H), 7.92 (s, 1H), 7.68 (s, 1H), 7.17 (d, 1H, J=8.4 Hz), 4.93 (s, 2H), 3.70-3.63 (m, 4H), 2.89 (s, 6H), 2.50 (s, 3H), 1.45 (s, 6H).
Workup
- filtrationThe precipitate was filtered
- filtrationfilter cake
- washwas washed with 2-methoxy-2-methylpropane (5 mL)
Sources & evidence
- ORD record
- ord-194de4feeba4488a8f1789e7a4d40cff
- Source dataset
- uspto-grants-2014_02
- Patent number
- US08658646B2
Reaction notes
Loading…